澳大利亚瓣膜手术后的结果：一个增强型数据库模块的开发
Outcome following valve surgery in Australia: development of an enhanced database module.
作者信息
Russell E Anne, Reid Christopher M, Walsh Warren F, Brown Alex, Maguire Graeme P
机构信息
Clinical Research Domain, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
School of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
出版信息
BMC Health Serv Res. 2017 Jan 17;17(1):43. doi: 10.1186/s12913-017-2002-0.
BACKGROUND
Valvular heart disease, including rheumatic heart disease (RHD), is an important cause of heart disease globally. Management of advanced disease can include surgery and other interventions to repair or replace affected valves. This article summarises the methodology of a study that will incorporate enhanced data collection systems to provide additional insights into treatment choice and outcome for advanced valvular disease including that due to RHD.
METHODS
An enhanced data collection system will be developed linking an existing Australian cardiac surgery registry to more detailed baseline co-morbidity, medication, echocardiographic and hospital separation data to identify predictors of morbidity and mortality outcome following valve surgery.
DISCUSSION
This project aims to collect and incorporate more detailed information regarding pre and postoperative factors and subsequent morbidity. We will use this to provide additional insights into treatment choice and outcome.
背景
包括风湿性心脏病（RHD）在内的心脏瓣膜病是全球心脏病的重要病因。晚期疾病的管理可包括手术及其他修复或置换受影响瓣膜的干预措施。本文总结了一项研究的方法，该研究将采用强化数据收集系统，以提供关于晚期瓣膜病（包括由RHD引起的瓣膜病）治疗选择和结局的更多见解。
方法
将开发一个强化数据收集系统，把现有的澳大利亚心脏外科手术登记系统与更详细的基线合并症、用药、超声心动图和住院分离数据相链接，以确定瓣膜手术后发病和死亡结局的预测因素。
讨论
该项目旨在收集并纳入有关术前和术后因素以及随后发病率的更详细信息。我们将利用这些信息来提供关于治疗选择和结局的更多见解。
Zotero 插件